Related Experiment Video

Updated: Dec 27, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.0K

Genetic modification of oncolytic viruses to enhance antitumor immunity

Maria Eugenia Davola1, Alyssa Vito2, Jiarun Wei2

  • 1Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada.

Methods in Enzymology
|March 4, 2020
PubMed

Insights

Oncolytic viruses (OVs) show promise for cancer treatment. Genetic modifications can enhance their ability to fight tumors and boost the immune system, improving cancer immunotherapy effectiveness.

Area of Science:

  • Oncolytic virotherapy
  • Cancer immunotherapy
  • Viral genetics

Background:

  • Oncolytic viruses (OVs) are emerging as potent therapeutic agents for cancer treatment.
  • A genetically engineered herpes simplex virus type 1 (HSV-1) has gained FDA approval for melanoma treatment.
  • Improving OV efficacy through genetic engineering is a key focus in cancer therapy research.

Purpose of the Study:

  • To explore genetic modifications of OVs to enhance their antitumor activity.
  • To investigate methods for increasing the immunostimulatory capacity of OVs.
  • To present analyses for verifying genetic modifications and evaluating their impact on antitumor immunity.

Main Methods:

  • Describing potential modifications within the OV genome.
  • Detailing various methods to achieve desired genetic alterations in OVs.
  • Presenting analytical techniques to confirm genetic changes and assess immune responses.

Main Results:

  • Identification of specific genomic modifications that can augment OV antitumor effects.
  • Demonstration of methods to enhance the immune-stimulating properties of engineered OVs.
  • Validation of analytical approaches for assessing OV modifications and their preliminary impact on host immunity.

Conclusions:

  • Genetic engineering of OVs offers a promising strategy to improve cancer immunotherapy.
  • Targeted modifications can significantly enhance OV antitumor efficacy and immunostimulatory potential.
  • Preclinical analyses are crucial for verifying modifications and evaluating their therapeutic impact.
Keywords:
Antitumor immune stimulationGenetic modificationHSV-1Homologous recombinationImmunotherapyOncolytic virus

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.4K
Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

8.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
880
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
860